Zoll Medical receives FDA IDE approval to begin ISO SHOCK (incorporating supersaturated oxygen in shock) feasibility study
May 13, 2021 – ZOLL Medical Corporation (Chelmsford, MA), an Asahi Kasei company, announced today the U.S. Food and Drug Administration (FDA) has approved an…